| Cas No.: | 1349796-36-6 |
| 名称: | N-(4-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide. |
| 别名: | SAR245409; XL-765;SAR 245409;SAR- 245409 |
| SMILES: | C(NC1=CC=C(S(NC2C(NC3=CC(OC)=CC(OC)=C3)=NC3C(N=2)=CC=CC=3)(=O)=O)C=C1)(=O)C1=CC=C(C)C(OC)=C1 |
| 分子式: | C31H29N5O6S |
| 分子量: | 599.66 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | XL-765, also known as SAR245409, is a PI3K/mTOR dual kinase inhibitor XL765 is an orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, w |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |




